CME America Gets 483 for Failure to Look Into Labeling After Complaints

The GMP Letter
CME America failed to investigate the adequacy of its device labeling following three MedWatch reports on administration sets that related to the way a customer was using the device, according to a Form 483 issued to the Golden, Colo., devicemaker.

To View This Article:


Subscribe To The GMP Letter

Buy This Article Now

Add this article to your cart for $135.00